Among neurological adverse reactions in patients with schizophrenia treated with antipsychotics (APs), drug-induced parkinsonism (DIP) is the most common motility disorder caused by drugs affecting dopamine receptors. One of the causes of DIP is the disruption of neurotransmitter interactions that regulate the signaling pathways of the dopaminergic, cholinergic, GABAergic, adenosinergic, endocannabinoid, and other neurotransmitter systems. Presently, the development mechanisms remain poorly understood despite the presence of the considered theories of DIP pathogenesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405702 | PMC |
| http://dx.doi.org/10.3390/biomedicines10082010 | DOI Listing |
Publication Analysis
Top Keywords
pathophysiological mechanisms
4
mechanisms antipsychotic-induced
4
antipsychotic-induced parkinsonism
4
parkinsonism neurological
4
neurological adverse
4
adverse reactions
4
reactions patients
4
patients schizophrenia
4
schizophrenia treated
4
treated antipsychotics
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!